Rim Halaby

EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention

C. Michael Gibson, Robert P. Giugliano, Robert A. Kloner et al. · European Heart Journal · 2015 · 154 citations · Full text

Atrial Substrate and Triggers of Paroxysmal Atrial Fibrillation in Patients With Obstructive Sleep Apnea

Elad Anter, Luigi Di Biase, Fernando M. Contreras‐Valdes et al. · Circulation Arrhythmia and Electrophysiology · 2017 · 125 citations · Full text

Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients

C. Michael Gibson, Gerald Chi, Rim Halaby et al. · Circulation · 2016 · 67 citations

Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation

Rim Halaby, Howard C. Herrmann, Zachary M. Gertz et al. · JACC: Cardiovascular Interventions · 2021 · 59 citations

Mitral Valve Gradient, Heart Failure, Secondary Mitral Regurgitation +6

The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial

C. Michael Gibson, Rim Halaby, Serge Korjian et al. · American Heart Journal · 2016 · 53 citations

Thrombosis, Venous Thrombosis, Cardiovascular Disease +9